Abstract
Complex biological systems exhibit a property of robustness at all levels of organization. Through different mechanisms, the system tries to sustain stress such as due to starvation or drug exposure. To explore whether reconfiguration of the metabolic networks is used as a means to achieve robustness, we have studied possible metabolic adjustments in Mtb upon exposure to isoniazid (INH), a front-line clinical drug. The redundancy in the genome of M. tuberculosis (Mtb) makes it an attractive system to explore if alternate routes of metabolism exist in the bacterium. While the mechanism of action of INH is well studied, its effect on the overall metabolism is not well characterized. Using flux balance analysis, inhibiting the fluxes flowing through the reactions catalyzed by Rv1484, the target of INH, significantly changes the overall flux profiles. At the pathway level, activation or inactivation of certain pathways distant from the target pathway, are seen. Metabolites such as NADPH are shown to reduce drastically, while fatty acids tend to accumulate. The overall biomass also decreases with increasing inhibition levels. Inhibition studies, pathway level clustering and comparison of the flux profiles with the gene expression data indicate the activation of folate metabolism, ubiquinone metabolism, and metabolism of certain amino acids. This analysis provides insights useful for target identification and designing strategies for combination therapy. Insights gained about the role of individual components of a system and their interactions will also provide a basis for reconstruction of whole systems through synthetic biology approaches.
Similar content being viewed by others
Abbreviations
- INH:
-
Isoniazid
- Mtb:
-
Mycobacterium tuberculosis
- InhA:
-
NADH-dependent enoyl [acyl-carrier-protein] reductase
- NAD(P):
-
Nicotinamide adenine dinucleotide (phosphate)
References
Argyrou A, Jin L, Siconilfi-Baez L, Angeletti RH, Blanchard JS (2006) Proteome-wide profiling of isoniazid targets in mycobacterium tuberculosis. Biochemistry 45(47):13947–13953
Awaness AM, Mitchison DA (1973) Cumulative effects of pulsed exposures of mycobacterium tuberculosis to isoniazid. Tubercle 54(2):153–158
Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, Herrgard MJ (2007) Quantitative prediction of cellular metabolism with constraint-based models: the cobra toolbox. Nat Protocols 2(3):727–738
Betts JC, McLaren A, Lennon MG, Kelly FM, Lukey PT, Blakemore SJ, Duncan K (2003) Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated mycobacterium tuberculosis. Antimicrob Agents Chemother 47(9):2903–2913
Boshoff HI, Myers TG, Copp BR, McNeil MR, Wilson MA, Barry CE 3rd (2004) The transcriptional responses of mycobacterium tuberculosis to inhibitors of metabolism: Novel insights into drug mechanisms of action. J Biol Chem 279(38):40174–40184. doi:10.1074/jbc.M406796200M406796200[pii]
Chandra N (2009) Computational systems approach for drug target discovery. Expert Opinion Drug Discov 4(12):1221–1236. doi:10.1517/17460440903380422
Cinquin O, Demongeot J (2002) Roles of positive and negative feedback in biological systems. Comptes Rendus Biologies 325(11):1085–1095
Gangadharam PR, Harold FM, Schaefer WB (1963) Selective inhibition of nucleic acid synthesis in mycobacterium tuberculosis by isoniazid. Nature 198:712–714
Goyal S, Yuan J, Chen T, Rabinowitz JD, Wingreen NS (2010) Achieving optimal growth through product feedback inhibition in metabolism. PLoS Comput Biol 6(6):e1000802
Jamshidi N, Palsson B (2007) Investigating the metabolic capabilities of mycobacterium tuberculosis H37Rv using the in-silico strain iNJ661 and proposing alternative drug targets. BMC Systems Biol 1(1):26
Kohanski MA, Dwyer DJ, Collins JJ (2010) How antibiotics kill bacteria: from targets to networks. Nat Rev Micro 8(6):423–435
Krause EF (1987) Taxicab geometry: an adventure in non-euclidean geometry. Mineola, NY: Dover
Pfeiffer T, Soyer OS, Bonhoeffer S (2005) The evolution of connectivity in metabolic networks. PLoS Biol 3(7):e228
Raman K, Rajagopalan P, Chandra N (2005) Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs. PLoS Comput Biol 1(5):e46
Raman K, Vashisht R, Chandra N (2009) Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis. Molecular BioSystems 5(12):1740–1751
Rawat R, Whitty A, Tonge PJ (2003) The isoniazid-nad adduct is a slow, tight-binding inhibitor of inha, the mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc Natl Acad Sci USA 100(24):13881–13886. doi:10.1073/pnas.2235848100
Schellenberger J, Park J, Conrad T, Palsson B (2010) BiGG: A biochemical genetic and genomic knowledgebase of large scale metabolic reconstructions. BMC Bioinformatics 11(1):213
Simon JW, Richard AS, Ken L, Laurent K, Robert CR, Robert CR, Gurdyal SB (2004) The use of microarray analysis to determine the gene expression profiles of mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinburgh, Scotland) 84(3):263–274
Takayama K, Wang L, David HL (1972) Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of mycobacterium tuberculosis. Antimicrob Agents Chemother 2(1):29–35
Xie L, Li J, Xie L, Bourne PE (2009) Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput Biol 5(5):e1000387
Zuroff T, Bernstein H, Lloyd-Randolfi J, Jimenez-Taracido L, Stewart P, Carlson R (2010) Robustness analysis of culturing perturbations on escherichia coli colony biofilm beta-lactam and aminoglycoside antibiotic tolerance. BMC Microbiol 10(1):185
Acknowledgments
We thank the Department of Biotechnology (DBT), Government of India and Open Source Drug Discovery program (CSIR) for financial support. The use of facilities at the Bioinformatics Centre, Indian Institute of Science is also gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ashwini G. Bhat and Rohit Vashisht contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bhat, A.G., Vashisht, R. & Chandra, N. Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid. Syst Synth Biol 4, 299–309 (2010). https://doi.org/10.1007/s11693-011-9075-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11693-011-9075-6